- Home
- BTAI vs TACT Comparison
BTAI vs TACT Comparison
Compare BTAI & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | TACT |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 35.7M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BTAI | TACT |
|---|---|---|
| Price | $1.22 | $3.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $23.00 | $5.00 |
| AVG Volume (30 Days) | ★ 735.8K | 29.4K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 75.63 | ★ 87.88 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | N/A |
| Revenue This Year | $197.82 | $10.36 |
| Revenue Next Year | $910.15 | N/A |
| P/E Ratio | ★ N/A | $49.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $3.06 |
| 52 Week High | $8.08 | $5.70 |
Technical Indicators
Market Signals| Indicator | BTAI | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 54.50 |
| Support Level | $1.02 | $3.22 |
| Resistance Level | $1.26 | $3.72 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 55.71 | 56.10 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.